Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Alexander Poulos
TipRanks Contributor
About
Alexander has extensive experience trading, which has been honed over the past 25 years. The biotech arena is an area of expertise as it allows Alexander to utilize his professional background to analyze the opportunity.
Alexander’s Recent Articles
Can Provention Bio Breathe Life Into Failed Eli Lilly Molecule?
In the biopharma space, innovation can come in unexpected ways. It is not unusual for a once discarded...
4y ago
Global Blood Therapeutics: Can This Biotech Still Disrupt The Sickle Cell Disease Space?
Global Blood Therapeutics (GBT) burst onto the biotech scene with a novel oral treatment for Sickle cell disease...
4y ago
GBT
Rubius Therapeutics Charts A New Path For Hard-To-Treat Cancers
Innovation is the crucial ingredient for market-beating gains. The innovators of the past decade, including Amazon, Google, and...
4y ago
bluebird bio Receives Positive Assessment Of Lead Product Lentiglobin
The share price of gene-therapy pioneer bluebird bio (BLUE) has come under intense selling pressure over the past...
4y ago
Acadia Pharmaceuticals: Is Potential Nuplazid Delay A Sign Of Trouble Or An Opportunity?
Acadia Pharmaceuticals’ (ACAD) share price was cut almost in half as doubt crept into investors’ minds as to...
4y ago
Horizon Therapeutics Pivots Towards Explosive Earnings Growth
Horizon Therapeutics (HZNP) has successfully transformed into a unique entity in the lucrative rare-disease space. The company burst...
4y ago
HZNP
bluebird bio: Positive Resolution Of Clinical Hold Could Drive Asymmetrical Upside
Shares of bluebird bio (BLUE) came under intense selling pressure following the announcement of a clinical hold on...
4y ago
Galapagos: Upside Optionality Remains Despite Clinical Trial Failure
Galapagos (GLPG) is far from a household name in the US, yet it remains a productive company that...
4y ago
Ultragenyx: Multiple Potential Catalysts Ahead
Ultragenyx (RARE) is on the cusp of transforming itself from a developmental stage entity into a stable, rare-drug...
4y ago
Esperion Therapeutics: The Good, Bad and Ugly
Overview The bull case for Esperion Therapeutics (ESPR) neatly falls into three categories. There is a lot to...
4y ago
ESPR
You need to enable JavaScript to run this app.
